Watchlist Price Alert

Virios Therapeutics Inc. (VIRI)

NASDAQ: VIRI · Real-Time Price · USD

0.15

0.01 (8.77%)

At close: Oct 08, 2024, 8:00 PM

Virios Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-1.05M	-1.29M	-1.1M	-1.24M	-1.44M	-1.52M	-2.04M	-2.58M	-3.67M	-3.96M	-4.51M	-4.11M	-4.28M	-3.06M	-6.5M	-2.72M	-654.59K	-466.55K	-638.59K	-811.82K	-567.86K	-511.61K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	53.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	148.95K	138.97K	148.31K	148.31K	161.66K	161.7K	149.53K	164.27K	136.96K	131.91K	131.91K	131.91K	34.24K	24.82K	5.43M	2M	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	138.36K	130.11K	-420.85K	135.25K	457.62K	438.07K	-703.81K	-51.99K	-461.68K	1.2M	-669.12K	1.11M	1.85M	-2.61M	-1.08M	129.55K	-181.01K	104.6K	170.31K	341.94K	-52.97K	-52.97K
Other Non-Cash Items	198.17K	54.12K	241.76K	157.24K	82.45K	599.77K	222.1K	184.07K	-197.89K	155.08K	261.54K	-89K	386.31K	-505.98K	-31.31K	2.01M	1.58K	10.72K	12.14K	12.32K	64.97K	8.72K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-53.98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	89.14K	214.95K	-514.3K	126.31K	536.83K	-343.28K	-776.38K	-71.79K	-126.83K	1.17M	-798.75K	1.33M	1.5M	-2.08M	-1.18M	150.39K	-119.56K	178.45K	154.74K	290.79K	-52.97K	-52.97K
Operating Cash Flow	-811.75K	-937.41K	-1.47M	-960.45K	-742.41K	-1.7M	-2.67M	-2.48M	-3.66M	-2.66M	-5.18M	-2.65M	-2.75M	-5.11M	-2.29M	-558.89K	-772.57K	-277.38K	-471.71K	-508.71K	-555.86K	-555.86K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	125K	706.63K	1.16M	580K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-86	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.45M	n/a	-1.16M	n/a	n/a	n/a	n/a	4.58M	n/a	n/a	n/a	n/a	n/a	-97.6K	31.58M	-115.52K	-80.08K	n/a	-5.57K	-10.82K	903.95K	903.95K
Financial Cash Flow	1.45M	n/a	2.31M	1.16M	n/a	n/a	-86K	4.58M	n/a	n/a	n/a	n/a	n/a	-97.6K	31.58M	9.48K	626.55K	1.16M	574.43K	-10.82K	903.95K	903.95K
Net Cash Flow	640.65K	-937.41K	-1.47M	195.99K	-742.41K	-1.7M	-2.76M	2.09M	-3.66M	-2.66M	-5.18M	-2.65M	-2.75M	-5.21M	29.3M	-549.41K	-146.01K	885.12K	102.72K	-519.53K	348.09K	348.09K
Free Cash Flow	-811.75K	-937.41K	-1.47M	-960.45K	-742.41K	-1.7M	-2.67M	-2.48M	-3.66M	-2.66M	-5.18M	-2.65M	-2.75M	-5.11M	-2.29M	-558.89K	-772.57K	-277.38K	-471.71K	-508.71K	-555.86K	-555.86K